| DC Field | Value | Language |
|---|
| dc.contributor.author | Gavrilova, A. A. | - |
| dc.contributor.author | Bontsevich, R. A. | - |
| dc.contributor.author | Vovk, Y. R. | - |
| dc.contributor.author | Balabanova, A. A. | - |
| dc.date.accessioned | 2022-05-05T08:24:31Z | - |
| dc.date.available | 2022-05-05T08:24:31Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Modern approaches to pharmacotherapy of community-acquired pneumonia / A.A. Gavrilova [et al.] // Research Results in Pharmacology. - 2020. - Vol.6, №4.-P. 77-84. - Doi: 10.3897/rrpharmacology.6.52318. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46609 | - |
| dc.description.abstract | The study presents current views on the pharmacotherapy of community-acquired pneumonia (CAP). This study also describes in general terms the current pharmacoepidemiological situation of the CAP in Russia and abroad, which can both help medical professionals make an informed choice when choosing a pharmacotherapy, and inspire them to follow-up research and observations | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | clinical recommendations | ru |
| dc.subject | antibiotics | ru |
| dc.subject | antimicrobial therapy | ru |
| dc.subject | COVID19 | ru |
| dc.subject | SARS-COV2 | ru |
| dc.subject | community-acquired | ru |
| dc.subject | pneumonia | ru |
| dc.title | Modern approaches to pharmacotherapy of community-acquired pneumonia | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 6, № 4
|
